Intestinal Diseases  >>  Monofer (iron isomaltoside 1000)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Monofer (iron isomaltoside 1000) / Pharmacosmos
NCT01017614 / 2009-012544-16: Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

Completed
3
350
Europe, RoW
Monofer, Iron Sulphate
Pharmacosmos A/S, Max Neeman International
Inflammatory Bowel Disease
07/12
08/12
NCT01410435 / 2011-001593-25: Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease

Completed
3
39
Europe
Monofer
Pharmacosmos A/S
Inflammatory Bowel Disease, Anaemia
08/13
09/13
NCT01599702: Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease

Completed
3
21
Europe
Iron Isomaltoside 1000, Monofer
Pharmacosmos A/S
Inflammatory Bowel Disease
12/14
12/14

Download Options